Beyond its primary location in pancreatic -cells, GLP-1 receptor (GLP-1R) has been identified in various other tissues, including the gastrointestinal tract, lung, kidney, heart, bone, central nervous system, liver, and adipose tissue (Bu et al., 2024)
The combination of GLP-1, GIP, and glucagon receptor activity produces metabolic and body composition research effects beyond what dual or single-receptor compounds deliver
The two compounds don't directly interact in the body
The DAC-modified version is designed for prolonged receptor engagement, while the No DAC form has a shorter activity window that supports pulsatile signaling studies
Ozempic has been shown to effectively support weight loss by reducing appetite, slowing stomach emptying, and increasing feelings of fullness
This hasnt been my personal experience, but it is something to keep in mind